Original Research
Accepted on 03 Nov 2025
Knowledge, Attitudes, and Practices of Inpatients with Chronic Cardiovascular Comorbidities Regarding Polypharmacy: A Cross-Sectional Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Type at least 3 characters
2,196 articles
Original Research
Accepted on 03 Nov 2025
Tuberculosis infection following administration of immune checkpoint inhibitors: a real world observational study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Review
Accepted on 03 Nov 2025
Substandard and falsified medicines in Africa: healthcare systems challenges, supply chain issues, regulatory challenges and strategies to increase access to quality medicines
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 31 Oct 2025
Cost-effectiveness analysis of irinotecan hydrochloride liposome in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 178 views
Correction
Accepted on 31 Oct 2025
Corrigendum: Cost-effectiveness analysis of cabozantinib plus atezolizumab for advanced hepatocellular carcinoma
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Original Research
Accepted on 30 Oct 2025
Pharmacist Prescriber Implementation in the Experiences of General Practitioners, Pharmacist Prescribers and Patients: Qualitative Study based on Pilot Trial in Slovenia
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
Brief Research Report
Published on 30 Oct 2025
Impact on health outcomes and productive work of adding anti-PD-1 agents to treat early-stage cancers in the United Kingdom: a modelling study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613120
- 487 views
Perspective
Published on 28 Oct 2025
Advances in clinical application on nursing intervention for ribavirin-associated adverse events
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596007
- 390 views
Systematic Review
Accepted on 27 Oct 2025
Comparative efficacy and safety of second-line therapies for patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis of randomized controlled trials
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 142 views
Original Research
Accepted on 27 Oct 2025
A comparative analysis of biologics market dynamics in 12 countries: (Bio)similar and sustainability
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 215 views
Original Research
Accepted on 27 Oct 2025
Pricing, Price Revision, and Clinical Value of Anticancer Drugs in Japan: A Retrospective Observational Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 141 views
Original Research
Published on 27 Oct 2025
Association between immune check point inhibitors and digestive system inflammatory adverse reactions: evidence from pharmacovigilance analysis and systematic review
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1684475
- 464 views
Original Research
Accepted on 24 Oct 2025
Implementation of Medication Review Type 2a in Community Pharmacies: A Longitudinal Survey Study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
- 347 views
Original Research
Published on 24 Oct 2025
Overcoming barriers to off-patent drug repurposing: a lifecycle-based policy solutions
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1670845
- 661 views
Original Research
Published on 23 Oct 2025
Adherence, satisfaction, and quality of life in Wilson disease patients after switching to trientine tetrahydrochloride: observational data from a dual cohort study
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1515686
- 753 views
Correction
Published on 22 Oct 2025
Correction: Psychiatric adverse events associated with infliximab: a cohort study from the French nationwide discharge abstract database
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1719490
- 268 views